COVER
COVER - shares | 6 Months Ended | |
Sep. 30, 2023 | Nov. 02, 2023 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-40508 | |
Entity Registrant Name | Doximity, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 27-2485512 | |
Entity Address, Address Line One | 500 3rd St. | |
Entity Address, Address Line Two | Suite 510 | |
Entity Address, City or Town | San Francisco | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 94107 | |
City Area Code | 650 | |
Local Phone Number | 549-4330 | |
Title of 12(b) Security | Class A common stock, $0.001 par value per share | |
Trading Symbol | DOCS | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001516513 | |
Current Fiscal Year End Date | --03-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Common Class A | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 118,159,500 | |
Common Class B | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 67,748,282 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 108,403 | $ 158,027 |
Marketable securities | 621,451 | 682,972 |
Accounts receivable, net of allowance for doubtful accounts of $1,103 and $887 at September 30, 2023 and March 31, 2023, respectively | 97,217 | 107,047 |
Prepaid expenses and other current assets | 32,789 | 22,289 |
Deferred contract costs, current | 2,960 | 5,118 |
Total current assets | 862,820 | 975,453 |
Property and equipment, net | 11,780 | 11,279 |
Deferred income tax assets | 39,289 | 34,907 |
Operating lease right-of-use assets | 12,743 | 13,819 |
Intangible assets, net | 29,440 | 31,836 |
Goodwill | 67,940 | 67,940 |
Other assets | 1,559 | 1,654 |
Total assets | 1,025,571 | 1,136,888 |
Current liabilities: | ||
Accounts payable | 714 | 1,272 |
Accrued expenses and other current liabilities | 29,086 | 31,245 |
Deferred revenue, current | 91,446 | 105,238 |
Operating lease liabilities, current | 1,935 | 1,752 |
Total current liabilities | 123,181 | 139,507 |
Deferred revenue, non-current | 237 | 198 |
Operating lease liabilities, non-current | 13,119 | 13,885 |
Contingent earn-out consideration liability, non-current | 10,448 | 15,942 |
Other liabilities, non-current | 7,119 | 1,240 |
Total liabilities | 154,104 | 170,772 |
Commitments and contingencies (Note 13) | ||
Stockholders' Equity | ||
Preferred stock, $0.001 par value; 100,000 shares authorized as of September 30, 2023 and March 31, 2023, respectively; zero shares issued and outstanding as of September 30, 2023 and March 31, 2023, respectively | 0 | 0 |
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of September 30, 2023 and March 31, 2023, respectively; 188,518 and 193,941 shares issued and outstanding as of September 30, 2023 and March 31, 2023, respectively | 188 | 194 |
Additional paid-in capital | 794,804 | 762,150 |
Accumulated other comprehensive loss | (8,928) | (14,083) |
Retained earnings | 85,403 | 217,855 |
Total stockholders’ equity | 871,467 | 966,116 |
Total liabilities and stockholders’ equity | $ 1,025,571 | $ 1,136,888 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts | $ 1,103 | $ 887 |
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, authorized (in shares) | 1,500,000,000 | 1,500,000,000 |
Common stock, issued (in shares) | 188,518,000 | 193,941,000 |
Common stock, outstanding (in shares) | 188,518,000 | 193,941,000 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 113,612 | $ 102,185 | $ 222,081 | $ 192,824 |
Cost of revenue | 12,759 | 13,210 | 25,912 | 26,287 |
Gross profit | 100,853 | 88,975 | 196,169 | 166,537 |
Operating expenses: | ||||
Research and development | 19,958 | 19,104 | 41,889 | 38,126 |
Sales and marketing | 30,201 | 29,021 | 64,656 | 57,155 |
General and administrative | 8,966 | 8,749 | 18,213 | 17,473 |
Restructuring | 7,936 | 0 | 7,936 | 0 |
Total operating expenses | 67,061 | 56,874 | 132,694 | 112,754 |
Income from operations | 33,792 | 32,101 | 63,475 | 53,783 |
Other income, net | 5,903 | 908 | 10,742 | 1,712 |
Income before income taxes | 39,695 | 33,009 | 74,217 | 55,495 |
Provision for income taxes | 9,093 | 6,710 | 15,209 | 6,813 |
Net income | $ 30,602 | $ 26,299 | $ 59,008 | $ 48,682 |
Net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in dollars per share) | $ 0.16 | $ 0.14 | $ 0.30 | $ 0.25 |
Diluted (in dollars per share) | $ 0.15 | $ 0.12 | $ 0.28 | $ 0.23 |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in shares) | 193,112 | 193,137 | 193,813 | 193,042 |
Diluted (in shares) | 209,014 | 213,949 | 210,681 | 214,452 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 30,602 | $ 26,299 | $ 59,008 | $ 48,682 |
Other comprehensive income (loss) | ||||
Change in unrealized gain (loss) on available-for-sale-securities, net of tax benefit (provision) of $(1,146), $1,235, $(1,736), and $2,130, respectively | 3,408 | (3,634) | 5,155 | (6,265) |
Comprehensive income | $ 34,010 | $ 22,665 | $ 64,163 | $ 42,417 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Change in unrealized loss on available-for-sale-securities, tax benefit (provision) | $ (1,146) | $ 1,235 | $ (1,736) | $ 2,130 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Class A and Class B Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Retained Earnings |
Beginning balance (in shares) at Mar. 31, 2022 | 192,398 | ||||
Beginning balance at Mar. 31, 2022 | $ 878,594 | $ 192 | $ 702,589 | $ (15,294) | $ 191,107 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 18,622 | 18,622 | |||
Exercise of stock options and common stock warrants (in shares) | 1,912 | ||||
Exercise of stock options and common stock warrants | 5,608 | $ 2 | 5,606 | ||
Vesting of restricted stock units (in shares) | 69 | ||||
Tax withholding on shares under stock-based compensation awards | (1,261) | (1,261) | |||
Repurchase and retirement of common stock, including excise tax (in shares) | (2,151) | ||||
Repurchase and retirement of common stock, including excise tax | (70,042) | $ (2) | (70,040) | ||
Common stock warrant expense | 2,685 | 2,685 | |||
Issuance of common stock in connection with the employee stock purchase plan (in shares) | 74 | ||||
Issuance of common stock in connection with the employee stock purchase plan | 2,341 | 2,341 | |||
Other comprehensive income (loss) | (6,265) | (6,265) | |||
Net income | 48,682 | 48,682 | |||
Ending balance (in shares) at Sep. 30, 2022 | 192,302 | ||||
Ending balance at Sep. 30, 2022 | 878,964 | $ 192 | 730,582 | (21,559) | 169,749 |
Beginning balance (in shares) at Jun. 30, 2022 | 193,336 | ||||
Beginning balance at Jun. 30, 2022 | 902,166 | $ 193 | 715,282 | (17,925) | 204,616 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 10,177 | 10,177 | |||
Exercise of stock options (in shares) | 708 | ||||
Exercise of stock options | 2,585 | $ 1 | 2,584 | ||
Vesting of restricted stock units (in shares) | 61 | ||||
Tax withholding on shares under stock-based compensation awards | (1,152) | (1,152) | |||
Repurchase and retirement of common stock, including excise tax (in shares) | (1,877) | ||||
Repurchase and retirement of common stock, including excise tax | (61,168) | $ (2) | (61,166) | ||
Common stock warrant expense | 1,350 | 1,350 | |||
Issuance of common stock in connection with the employee stock purchase plan (in shares) | 74 | ||||
Issuance of common stock in connection with the employee stock purchase plan | 2,341 | 2,341 | |||
Other comprehensive income (loss) | (3,634) | (3,634) | |||
Net income | 26,299 | 26,299 | |||
Ending balance (in shares) at Sep. 30, 2022 | 192,302 | ||||
Ending balance at Sep. 30, 2022 | 878,964 | $ 192 | 730,582 | (21,559) | 169,749 |
Beginning balance (in shares) at Mar. 31, 2023 | 193,941 | ||||
Beginning balance at Mar. 31, 2023 | 966,116 | $ 194 | 762,150 | (14,083) | 217,855 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | $ 25,307 | 25,307 | |||
Exercise of stock options (in shares) | 2,380 | 2,380 | |||
Exercise of stock options | $ 7,254 | $ 2 | 7,252 | ||
Vesting of restricted stock units (in shares) | 320 | ||||
Tax withholding on shares under stock-based compensation awards | (4,084) | (4,084) | |||
Repurchase and retirement of common stock, including excise tax (in shares) | (8,200) | ||||
Repurchase and retirement of common stock, including excise tax | (191,468) | $ (8) | (191,460) | ||
Common stock warrant expense | 2,685 | 2,685 | |||
Issuance of common stock in connection with the employee stock purchase plan (in shares) | 77 | ||||
Issuance of common stock in connection with the employee stock purchase plan | 1,494 | 1,494 | |||
Other comprehensive income (loss) | 5,155 | 5,155 | |||
Net income | 59,008 | 59,008 | |||
Ending balance (in shares) at Sep. 30, 2023 | 188,518 | ||||
Ending balance at Sep. 30, 2023 | 871,467 | $ 188 | 794,804 | (8,928) | 85,403 |
Beginning balance (in shares) at Jun. 30, 2023 | 194,649 | ||||
Beginning balance at Jun. 30, 2023 | 990,787 | $ 195 | 777,772 | (12,336) | 225,156 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Stock-based compensation | 12,348 | 12,348 | |||
Exercise of stock options (in shares) | 1,129 | ||||
Exercise of stock options | 3,961 | $ 1 | 3,960 | ||
Vesting of restricted stock units (in shares) | 199 | ||||
Tax withholding on shares under stock-based compensation awards | (2,120) | (2,120) | |||
Repurchase and retirement of common stock, including excise tax (in shares) | (7,536) | ||||
Repurchase and retirement of common stock, including excise tax | (170,363) | $ (8) | (170,355) | ||
Common stock warrant expense | 1,350 | 1,350 | |||
Issuance of common stock in connection with the employee stock purchase plan (in shares) | 77 | ||||
Issuance of common stock in connection with the employee stock purchase plan | 1,494 | 1,494 | |||
Other comprehensive income (loss) | 3,408 | 3,408 | |||
Net income | 30,602 | 30,602 | |||
Ending balance (in shares) at Sep. 30, 2023 | 188,518 | ||||
Ending balance at Sep. 30, 2023 | $ 871,467 | $ 188 | $ 794,804 | $ (8,928) | $ 85,403 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities | ||
Net income | $ 59,008 | $ 48,682 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 5,208 | 4,959 |
Deferred income taxes | 0 | 105 |
Stock-based compensation, net of amounts capitalized | 27,448 | 20,859 |
Non-cash lease expense | 1,077 | 952 |
Amortization of premium (accretion of discount) on marketable securities, net | (1,794) | 2,673 |
Loss on sale and redemption of marketable securities | 142 | 500 |
Amortization of deferred contract costs | 4,730 | 4,839 |
Other | (15) | 7 |
Changes in operating assets and liabilities, net of effect of acquisition: | ||
Accounts receivable | 9,644 | 2,194 |
Prepaid expenses and other assets | (10,504) | 3,651 |
Deferred contract costs | (2,448) | (2,342) |
Accounts payable, accrued expenses and other liabilities | (8,063) | (4,474) |
Deferred revenue | (13,753) | 1,872 |
Operating lease liabilities | (582) | (211) |
Net cash provided by operating activities | 70,098 | 84,266 |
Cash flows from investing activities | ||
Cash paid for acquisition | 0 | (53,500) |
Purchases of property and equipment | (111) | (1,476) |
Internal-use software development costs | (2,732) | (2,466) |
Purchases of marketable securities | (180,226) | (91,177) |
Maturities of marketable securities | 212,768 | 24,438 |
Sales of marketable securities | 37,525 | 64,158 |
Net cash provided by (used in) investing activities | 67,224 | (60,023) |
Cash flows from financing activities | ||
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | 7,218 | 5,584 |
Proceeds from issuance of common stock in connection with the employee stock purchase plan | 1,494 | 2,341 |
Taxes paid related to net share settlement of equity awards | (4,084) | (1,261) |
Repurchase of common stock | (186,184) | (70,042) |
Payment of contingent consideration related to a business combination | (5,390) | 0 |
Net cash used in financing activities | (186,946) | (63,378) |
Net decrease in cash and cash equivalents | (49,624) | (39,135) |
Cash and cash equivalents, beginning of period | 158,027 | 112,809 |
Cash and cash equivalents, end of period | 108,403 | 73,674 |
Supplemental disclosures of cash flow information | ||
Cash paid for taxes, net of refunds | 29,438 | 123 |
Non-cash financing and investing activities | ||
Fair value of contingent earn-out consideration included in purchase consideration | 0 | 21,134 |
Operating lease right-of-use assets obtained in exchange for operating lease liabilities | 0 | 14,759 |
Share repurchases included in accrued expenses | 5,003 | 0 |
Excise tax payable on share repurchases | $ 1,030 | $ 0 |
Description of Business
Description of Business | 6 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business | Description of BusinessDoximity, Inc. (the “Company”) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, monitor their work schedules, and manage their careers. The Company’s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company’s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023. The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, stockholders’ equity, and cash flows. The results of operations for the three and six months ended September 30, 2023, shown in this report are not necessarily indicative of the results to be expected for the full year ending March 31, 2024. Fiscal Year The Company’s fiscal year ends on March 31 st . Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year. Use of Estimates The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company’s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company’s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any. Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company’s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows: Revenue Accounts Receivable, Net Three Months Ended September 30, Six Months Ended September 30, September 30, 2023 March 31, 2023 2023 2022 2023 2022 Customer A * * * * 13 % 18 % Customer B * * * * 12 % * _______________ * Less than 10% For the purpose of assessing the concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company’s services directly or indirectly through marketing agencies. Restructuring Restructuring expense primarily consists of severance payments, employee benefits, and stock-based compensation in relation to the modification of equity awards associated with the management-approved plan. One-time employee termination benefits are recognized at the time of communication of the terms of the plan to the employees, unless future service is required, in which case the costs are recognized over the future service period. The Company records these costs in restructuring expense in the condensed consolidated statements of operations. Other than the description listed above, there have been no material changes to the significant accounting policies of the Company during the six months ended September 30, 2023 as compared to those described in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 and filed with the SEC on May 26, 2023. |
Revenue Recognition
Revenue Recognition | 6 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue Recognition | Revenue Recognition The Company’s revenue is primarily derived from the sale of subscriptions for the following solutions: • Marketing Solutions : Hosting of customer-sponsored content on the Doximity platform and providing access to the Company’s professional database of healthcare professionals for referral or marketing purposes during the subscription period. • Hiring Solutions : Providing customers access to the Company’s professional tools where recruiters can access the Company’s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers , through the following five steps: 1) Identify the contract with a customer The Company considers the terms and conditions of its contracts and the Company’s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party’s rights regarding the services to be transferred and the payment terms for the services, it has determined that the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s payment history or, in the case of a new customer, the customer’s credit and financial information. Contractual terms for Marketing Solutions contracts are generally 12 months or less. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions contracts are cancellable with a customary notice period. The Company does not refund prepaid amounts, and customers are responsible for prorated amounts to cover services that were provided but payment was not made. The contractual term for Hiring Solutions contracts is generally 12 months. Hiring Solutions contracts are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the customers’ marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company’s Awareness modules may include a sponsored article, short animated videos or other short-form content that is presented to the targeted member. Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress. Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period, subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. 3) Determine the transaction price The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur. The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company’s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price (“SSP”). The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on historical arrangements sold on a standalone basis. To the extent historical sales are not available or do not provide sufficient evidence, the Company takes into account several different factors, including but not limited to the overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The Company estimates the SSP for arrangements where standalone sales do not provide sufficient evidence of the SSP. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606. 5) Recognize revenue when or as the Company satisfies a performance obligation Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company’s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company’s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations, with revenue commencing upon the beginning of the subscription period. The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services and is recognized ratably over the subscription period. Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenue Disaggregation Revenue consisted of the following (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Subscription $ 106,654 $ 95,333 $ 207,909 $ 179,048 Other 6,958 6,852 14,172 13,776 Total revenue $ 113,612 $ 102,185 $ 222,081 $ 192,824 Contract Balances Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract, while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company’s contracts do not contain significant financing components. The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the condensed consolidated balance sheets within prepaid expenses and other current assets. The Company’s unbilled revenue balances were $1.8 million and $2.2 million as of September 30, 2023 and March 31, 2023, respectively. Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company’s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material. Revenue recognized for the three months ended September 30, 2023 and 2022 from amounts included in deferred revenue as of the beginning of the period was $71.4 million and $64.3 million, respectively. Revenue recognized for the six months ended September 30, 2023 and 2022 from amounts included in deferred revenue as of the beginning of the period was $97.1 million and $75.6 million, respectively. Deferred Contract Costs The Company capitalizes sales compensation that is considered to be an incremental and recoverable cost of obtaining a contract with a customer. Sales compensation earned for the renewal of Marketing Solutions contracts is commensurate with compensation earned for a new or expansion Marketing Solutions contract, whereas compensation for the renewal of Hiring Solutions subscription contracts is earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 14 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company’s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. The portion of deferred compensation expected to be recognized within one year of the balance sheet date is recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the condensed consolidated balance sheets. The amortization of deferred contract costs is included in sales and marketing expense in the condensed consolidated statements of operations. Sales compensation that is not considered an incremental cost is expensed in the same period that it was earned. The Company capitalized $1.2 million and $2.4 million of contract acquisition costs for the three and six months ended September 30, 2023, respectively, and $1.5 million and $2.3 million of contract acquisition costs for the three and six months ended September 30, 2022, respectively. Amortization of deferred contract costs was $2.0 million and $4.7 million for the three and six months ended September 30, 2023, respectively, and $2.1 million and $4.8 million for the three and six months ended September 30, 2022, respectively. |
Investments
Investments | 6 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments | Investments The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands): As of September 30, 2023 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 9,988 $ — $ (3) $ 9,985 Money market funds 71,842 — — 71,842 Total cash equivalents 81,830 — (3) 81,827 Marketable securities: Asset-backed securities 6,673 1 (12) 6,662 Certificates of deposit 11,965 1 (15) 11,951 Commercial paper 99,773 4 (41) 99,736 Corporate notes and bonds 66,351 1 (266) 66,086 Sovereign bonds 7,746 — (269) 7,477 U.S. government and agency securities 440,905 15 (11,381) 429,539 Total marketable securities 633,413 22 (11,984) 621,451 Total cash equivalents and marketable securities $ 715,243 $ 22 $ (11,987) $ 703,278 As of September 30, 2023, the contractual maturities of the Company’s available-for-sale debt securities were as follows (in thousands): Fair Value Due within one year $ 583,534 Due in one to two years 41,240 Asset-backed securities 6,662 Total $ 631,436 Actual maturities may differ from contractual maturities because certain borrowers have the right to call or prepay certain obligations. The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands): As of March 31, 2023 Cost or Gross Gross Fair Value Cash equivalents: Money market funds $ 126,275 $ — $ — $ 126,275 Total cash equivalents 126,275 — — 126,275 Marketable securities: Asset-backed securities 7,271 — (71) 7,200 Certificates of deposit 27,380 — (80) 27,300 Commercial paper 78,609 6 (126) 78,489 Corporate notes and bonds 119,241 49 (778) 118,512 Sovereign bonds 7,744 — (360) 7,384 U.S. government and agency securities 461,584 12 (17,509) 444,087 Total marketable securities 701,829 67 (18,924) 682,972 Total cash equivalents and marketable securities $ 828,104 $ 67 $ (18,924) $ 809,247 As of September 30, 2023 and March 31, 2023, the Company has recognized accrued interest of $2.5 million and $2.8 million, respectively, which is included in prepaid expenses and other current assets in the condensed consolidated balance sheets. The unrealized losses associated with the Company’s debt securities were $12.0 million and $18.9 million as of September 30, 2023 and March 31, 2023, respectively. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of September 30, 2023 or March 31, 2023. The Company did not recognize any credit losses related to the Company’s debt securities as of September 30, 2023 or March 31, 2023. The fair value related to the debt securities with unrealized losses for which no credit losses were recognized was $588.0 million and $653.4 million as of September 30, 2023 and March 31, 2023, respectively. The following tables summarize the gross unrealized losses and fair values of investments in an unrealized loss position, aggregated by security type and length of time that the individual securities have been in a continuous unrealized loss position (in thousands): As of September 30, 2023 Less than 12 months 12 months or greater Total Fair Value Gross Fair Value Gross Fair Value Gross Asset-backed securities $ 4,569 $ (8) $ 1,018 $ (4) $ 5,587 $ (12) Certificates of deposit 11,006 (15) — — 11,006 (15) Commercial paper 96,131 (44) — — 96,131 (44) Corporate notes and bonds 55,618 (139) 6,241 (127) 61,859 (266) Sovereign bonds — — 7,477 (269) 7,477 (269) U.S. government and agency securities 42,925 (75) 362,967 (11,306) 405,892 (11,381) Total $ 210,249 $ (281) $ 377,703 $ (11,706) $ 587,952 $ (11,987) As of March 31, 2023 Less than 12 months 12 months or greater Total Fair Value Gross Fair Value Gross Fair Value Gross Asset-backed securities $ 2,601 $ (12) $ 4,599 $ (59) $ 7,200 $ (71) Certificates of deposit 27,018 (80) — — 27,018 (80) Commercial paper 70,681 (126) — — 70,681 (126) Corporate notes and bonds 42,575 (113) 58,766 (665) 101,341 (778) Sovereign bonds — — 7,384 (360) 7,384 (360) U.S. government and agency securities — — 439,748 (17,509) 439,748 (17,509) Total $ 142,875 $ (331) $ 510,497 $ (18,593) $ 653,372 $ (18,924) |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Available-for-sale debt securities are recorded at fair value on the condensed consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1 —Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 —Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 —Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. The following tables present the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands): As of September 30, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 9,985 $ — $ 9,985 Money market funds 71,842 — — 71,842 Total cash equivalents 71,842 9,985 — 81,827 Marketable securities: Asset-backed securities — 6,662 — 6,662 Certificates of deposit — 11,951 — 11,951 Commercial paper — 99,736 — 99,736 Corporate notes and bonds — 66,086 — 66,086 Sovereign bonds — 7,477 — 7,477 U.S. government and agency securities 415,280 14,259 — 429,539 Total marketable securities 415,280 206,171 — 621,451 Total cash equivalents and marketable securities $ 487,122 $ 216,156 $ — $ 703,278 Liabilities: Contingent earn-out consideration liability $ — $ — $ 16,178 $ 16,178 Total contingent earn-out consideration liability $ — $ — $ 16,178 $ 16,178 As of March 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 126,275 $ — $ — $ 126,275 Total cash equivalents 126,275 — — 126,275 Marketable securities: Asset-backed securities — 7,200 — 7,200 Certificates of deposit — 27,300 — 27,300 Commercial paper — 78,489 — 78,489 Corporate notes and bonds — 118,512 — 118,512 Sovereign bonds — 7,384 — 7,384 U.S. government and agency securities 439,748 4,339 — 444,087 Total marketable securities 439,748 243,224 — 682,972 Total cash equivalents and marketable securities $ 566,023 $ 243,224 $ — $ 809,247 Liabilities: Contingent earn-out consideration liability $ — $ — $ 21,862 $ 21,862 Total contingent earn-out consideration liability $ — $ — $ 21,862 $ 21,862 During the six months ended September 30, 2023 and 2022, the Company had no transfers between levels of the fair value hierarchy. Contingent Earn-out Consideration Liability The following table summarizes the changes in the contingent earn-out consideration liability (in thousands): Six Months Ended September 30, 2023 2022 Beginning fair value $ 21,862 $ — Additions in the period — 21,134 Change in fair value 316 (94) Payments (6,000) — Ending fair value $ 16,178 $ 21,040 The contingent earn-out consideration liability relates to the AMiON acquisition, which closed on April 1, 2022. The fair value of the liability is remeasured at each reporting date until the related contingency is resolved, with any changes to the fair value recognized as sales and marketing expense in the condensed consolidated statements of operations. To determine the fair value of the contingent earn-out consideration liability, the Company used the discounted cash flow method. The significant inputs used in the fair value measurement of the contingent earn-out consideration liability are the discount rate and the timing and amounts of the future payments, which are based upon estimates of future achievement of the performance metrics. As these inputs are not based on observable market data, they represent a Level 3 measurement within the fair value hierarchy. Changes in the significant inputs used would significantly impact the fair value of the contingent earn-out consideration liability. |
Property and Equipment, Net
Property and Equipment, Net | 6 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): September 30, 2023 March 31, 2023 Furniture and equipment $ 2,846 $ 2,816 Computers and software 745 745 Leasehold improvements 982 888 Internal-use software development costs 23,366 20,405 Total property and equipment 27,939 24,854 Less: accumulated depreciation and amortization (16,159) (13,575) Total property and equipment, net $ 11,780 $ 11,279 Depreciation and amortization expense on property and equipment for the three and six months ended September 30, 2023 was $1.4 million and $2.8 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $1.2 million and $2.4 million for the three and six months ended September 30, 2023, respectively. Depreciation and amortization expense on property and equipment for the three and six months ended September 30, 2022 was $1.4 million and $2.6 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $1.2 million and $2.3 million for the three and six months ended September 30, 2022, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the condensed consolidated statements of operations. During the three and six months ended September 30, 2023, the Company capitalized $1.5 million and $3.3 million, respectively, and during the three and six months ended September 30, 2022, capitalized $1.2 million and $2.9 million, respectively, of internal-use software development costs, which are included in property and equipment, net in the condensed consolidated balance sheets. No impairment was recognized on property and equipment during the three and six months ended September 30, 2023 and 2022. |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 6 Months Ended |
Sep. 30, 2023 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, 2023 March 31, 2023 Accrued commissions $ 3,570 $ 5,733 Accrued payroll, bonus, and related expenses 7,444 8,739 Employee contributions under employee stock purchase plan 529 589 Rebate liabilities 681 3,348 Sales and other tax liabilities 2,210 1,504 Current portion of contingent earn-out consideration liability 5,730 5,920 Restructuring liability 541 — Share repurchase liability 5,003 748 Other 3,378 4,664 Total accrued expenses and other current liabilities $ 29,086 $ 31,245 |
Business Combinations
Business Combinations | 6 Months Ended |
Sep. 30, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations AMiON Acquisition On April 1, 2022, the Company completed the acquisition of the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians (“the AMiON acquisition”) to further expand our physician cloud platform. The acquisition-date fair value of the consideration was $74.6 million, consisting of $53.5 million in cash and $21.1 million in fair value of contingent earn-out consideration. Under the definitive agreement for the AMiON acquisition, the Company will pay contingent earn-out consideration of up to $24.0 million, of which $4.0 million is a minimum guarantee and the remaining $20.0 million is subject to the achievement of certain operational performance metrics over the next four years. The contingent earn-out consideration is payable in cash in annual installments over the next four years. The contingent earn-out consideration is classified as a liability, the short-term portion of which is included in accrued expenses and other current liabilities and the long-term portion is in contingent earn-out consideration liability, non-current in the condensed consolidated balance sheets. During the six months ended September 30, 2023, $6.0 million of the contingent earn-out consideration was settled. See Note 5—Fair Value Measurements for additional information regarding the valuation of the contingent earn-out consideration liability. Additionally, in May 2022, 93,458 RSUs with a grant date fair value of $32.99 per share were granted to the eligible employees joining the Company in connection with the AMiON acquisition. The shares will vest on a quarterly basis over four years based on continued service. The aggregate grant date fair value of these RSUs is accounted for as post-acquisition stock-based compensation expense and is recognized on a straight-line basis over the requisite service period. The AMiON acquisition was accounted for as a business combination. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands): Assets acquired: Accounts receivable $ 447 Customer relationships 27,200 Developed technology 820 Trademark 700 Total assets acquired $ 29,167 Liabilities assumed: Deferred revenue $ 2,925 Other liabilities 633 Net assets acquired, excluding goodwill 25,609 Goodwill $ 49,025 Total purchase consideration $ 74,634 Goodwill generated from the AMiON acquisition represents the future benefits from the development of future customer relationships and the assembled workforce. Goodwill from this business combination is deductible for income tax purposes. Intangible assets acquired are comprised of customer relationships, trademarks, and developed technology with estimated useful lives of 9 years, 3 years, and 18 months, respectively. The fair value assigned to the customer relationships was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the condensed consolidated financial statements from the acquisition date. The acquisition-related costs were not material and were recorded as general and administrative expense in the condensed consolidated statements of operations. |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 6 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Goodwill | Intangible Assets and Goodwill Intangible Assets Intangible assets, net consisted of the following (in thousands): September 30, 2023 March 31, 2023 Customer relationships $ 37,069 $ 37,069 Other intangibles 1,531 1,531 Total intangible assets 38,600 38,600 Less: accumulated amortization (9,160) (6,764) Total intangible assets, net $ 29,440 $ 31,836 Amortization expense for intangible assets was $1.2 million and $2.4 million for the three and six months ended September 30, 2023 and 2022, respectively. No impairment charges on intangible assets were recorded during the three and six months ended September 30, 2023 and 2022. As of September 30, 2023, future amortization expense is as follows (in thousands): Year Ending March 31, Amount Remainder of 2024 $ 2,123 2025 4,245 2026 4,012 2027 4,010 2028 4,010 2029 4,010 Thereafter 7,030 Total future amortization expense $ 29,440 Goodwill |
Equity
Equity | 6 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Equity | Equity Preferred Stock In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of September 30, 2023 and March 31, 2023, there were no shares of preferred stock issued and outstanding. Common Stock and Creation of Dual-Class Structure The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company’s board of directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company’s 85,523,836 shares of then-existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of September 30, 2023, there were 120,768,274 shares of Class A common stock, and 67,750,282 shares of Class B common stock outstanding. Stock Repurchase Program On May 12, 2022, the Company’s board of directors authorized a program to repurchase up to $70 million of the Company’s Class A common stock. As of September 30, 2022, the Company repurchased and retired 2,150,982 shares of Class A common stock for an aggregate purchase price of $70 million, thereby completing this share repurchase program. On October 28, 2022, the Company’s board of directors authorized an additional program to repurchase up to $70 million of the Company’s Class A common stock over a period of 12 months. In addition, on June 1, 2023, the Company’s board of directors authorized a program to repurchase up to $200 million of the Company’s Class A common stock over a period of 24 months. The repurchases are subject to general business and market conditions and other investment opportunities and may be executed through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. As of September 30, 2023, the Company repurchased and retired 8,723,200 shares of Class A common stock for an aggregate purchase price of $207.5 million under these repurchase programs, which includes excise taxes and the cost of commissions of $1.2 million. As of September 30, 2023, $63.7 million remained available and authorized for repurchase, excluding commissions and excise taxes. Common Stock Warrants In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News & World Report, L.P., or U.S. News. The warrant expires 10 years from the date of grant. As of September 30, 2023, the warrant was fully vested. 125,000 shares with an intrinsic value of $4.0 million were exercised under the warrant during the six months ended September 30, 2022, while no shares were exercised during the six months ended September 30, 2023. The remaining 125,000 shares under the warrant were outstanding as of September 30, 2023. In October 2021, the Company issued a warrant to U.S. News (the “U.S. News Warrant”) to purchase 516,000 shares of Class A common stock with an exercise price of $12.56 per share in connection with the execution of a commercial agreement with U.S. News (the “Commercial Agreement”). The U.S. News Warrant expires 10 years from the date of grant. The first tranche of the U.S. News Warrant vested on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant is recognized as expense in cost of revenue in the condensed consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. During the six months ended September 30, 2023 and 2022, $2.7 million was recognized as stock-based compensation expense relating to the U.S. News Warrant, respectively. As of September 30, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to the unvested warrants was $24.1 million, which is expected to be recognized over the remaining vesting period of 4.50 years. Equity Incentive Plans The Company maintains three equity incentive plans: the 2010 Equity Incentive Plan (the “2010 Plan”), the 2021 Stock Option and Incentive Plan (the “2021 Plan”), and the 2021 Employee Stock Purchase Plan (the “ESPP”). Upon IPO, the 2021 Plan became effective and the 2010 Plan was terminated. The 2010 Plan continues to govern the terms of outstanding awards that were granted prior to the termination of the 2010 Plan. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. The Company granted stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. During fiscal 2018, the Company granted 4,682,582 options outside of the Plans, of which 2,027,917 options were exercised and 2,654,665 were outstanding as of September 30, 2023. The Company has shares of common stock reserved for issuance as follows (in thousands): September 30, 2023 Common stock warrants 641 2010 Plan Options outstanding 16,664 2021 Plan Awards outstanding 2,159 Shares available for future grant 41,195 2021 ESPP 8,104 Options outstanding outside the plans 2,655 Total 71,418 Stock Options Stock options granted generally vest over four years with service-based, performance-based, and/or market-based conditions and expire ten years from the date of grant. Stock option activities within the Plans as well as outside of the Plans were as follows: Number of Shares Weighted-Average Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Balance, March 31, 2023 22,407 $ 4.39 6.56 $ 627,187 Options exercised (2,380) 3.05 Options forfeited or expired (708) 5.47 Balance, September 30, 2023 19,319 4.51 6.12 322,735 Vested and exercisable as of September 30, 2023 11,804 2.93 5.40 215,941 Vested and expected to vest as of September 30, 2023 18,740 4.44 6.09 314,519 The aggregate intrinsic value of options exercised during the six months ended September 30, 2023 and 2022 was $61.8 million and $60.2 million, respectively. As of September 30, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested stock options was $27.6 million, which is expected to be recognized over a weighted-average period of 2.77 years. The Company has not granted any stock options since the first quarter of fiscal 2022. Restricted Stock Units (“RSUs”) RSUs granted by the Company generally vest over four years based on continued service. The following table summarizes RSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2023 1,951 $ 40.08 Granted 749 30.02 Vested (392) 38.44 Forfeited (372) 44.59 Unvested balance, September 30, 2023 1,936 35.46 The total fair value of RSUs vested during the six months ended September 30, 2023 and 2022 was $11.3 million and $3.3 million, respectively. As of September 30, 2023, total unrecognized stock-based compensation expense, net of estimated forfeitures, related to unvested RSUs was $54.3 million, which is expected to be recognized over a weighted-average period of 2.99 years. Performance-Based Restricted Stock Units (“PSUs”) The PSUs have service-based and performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. The following table summarizes PSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2023 206 $ 34.68 Granted 156 33.74 Vested (78) 36.96 Forfeited (61) 35.07 Unvested balance, September 30, 2023 223 33.10 The total fair value of PSUs vested during the six months ended September 30, 2023 and 2022 was $1.8 million and $0.4 million, respectively. As of September 30, 2023, unamortized stock-based compensation expense, net of estimated forfeitures, related to unvested PSUs that are probable of vesting was $1.9 million, and is expected to be recognized over a weighted-average period of 1.54 years. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 2,278 $ 2,392 $ 4,739 $ 4,514 Research and development 2,538 2,862 5,794 5,414 Sales and marketing 2,697 3,982 8,692 7,056 General and administrative 2,288 2,117 4,577 3,875 Restructuring 3,646 — 3,646 — Total stock-based compensation expense $ 13,447 $ 11,353 $ 27,448 $ 20,859 |
Net Income Per Share Attributab
Net Income Per Share Attributable to Common Stockholders | 6 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Net Income Per Share Attributable to Common Stockholders | Net Income Per Share Attributable to Common Stockholders The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Numerator Net income $ 30,602 $ 26,299 $ 59,008 $ 48,682 Denominator Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic 193,112 193,137 193,813 193,042 Dilutive effect of stock options 15,673 20,595 16,573 21,178 Dilutive effect of common stock warrants 122 123 122 155 Dilutive effect of other share-based awards 107 94 173 77 Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted 209,014 213,949 210,681 214,452 Net income per share attributable to Class A and Class B common stockholders: Basic $ 0.16 $ 0.14 $ 0.30 $ 0.25 Diluted $ 0.15 $ 0.12 $ 0.28 $ 0.23 The dilutive effect of stock options, common stock warrants, RSUs, PSUs, and the ESPP is reflected in diluted earnings per share using the treasury stock method. Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Other share-based awards 1,665 511 911 512 Common stock warrants 516 516 516 516 Total 2,181 1,027 1,427 1,028 |
Restructuring
Restructuring | 6 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | RestructuringIn August 2023, the Company announced a restructuring plan (the “Restructuring Plan”) intended to simplify the Company’s operations and better align the Company’s resources with its priorities. The Restructuring Plan included a reduction of the Company’s workforce by approximately 10%. The actions associated with the workforce reduction under the Restructuring Plan were substantially completed as of September 30, 2023. The Company incurred $7.9 million in restructuring expense in the second quarter of fiscal 2024 in connection with the workforce reduction under the Restructuring Plan, consisting of $4.3 million of severance payments and employee benefits and $3.6 million of stock-based compensation expense for the accelerated vesting of equity awards. The following table summarizes the activities related to the Restructuring Plan as of September 30, 2023 (in thousands): Workforce Reduction Liability as of July 1, 2023 $ — Charges 4,289 Payments (3,748) Liability as of September 30, 2023 $ 541 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Minimum Guarantees On October 8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays U.S. News a portion of the revenue generated with the end customers, subject to annual minimum guarantees. As of September 30, 2023, the remaining annual minimum guarantees ranged from $3.6 million to $6.2 million. The total minimum guarantee for the remaining noncancelable period of one year was $3.6 million, which is expected to be paid within one year. Other Contractual Commitments Other contractual commitments relate mainly to third-party cloud infrastructure agreements and subscription agreements used to facilitate the Company’s operations. The Company has a web hosting arrangement for 3 years ending December 31, 2024, with an annual commitment of $5.2 million. As of September 30, 2023, the total remaining commitment was $5.2 million, which is expected to be paid within one year. Indemnification The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company’s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company’s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions. In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no material claims under these indemnification provisions. Legal Matters |
Leases
Leases | 6 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Leases | Leases The Company has non-cancelable operating leases for the rental of office space with various expiration dates through 2030. The components of lease expense were as follows (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 701 $ 701 $ 1,402 $ 1,190 Variable lease cost 45 133 65 173 Total lease cost $ 746 $ 834 $ 1,467 $ 1,363 Supplemental cash flow information related to leases was as follows (in thousands): Six Months Ended September 30, 2023 2022 Cash paid for amounts included in measurement of lease liabilities—Operating cash flows $ 907 $ 389 Supplemental balance sheet information related to leases was as follows: September 30, 2023 March 31, 2023 Weighted-average remaining lease term (in years) 6.68 7.06 Weighted-average discount rate 4.19 % 4.18 % Maturities of operating lease liabilities as of September 30, 2023 were as follows (in thousands): Remainder of 2024 $ 1,331 2025 2,411 2026 2,458 2027 2,497 2028 2,605 Thereafter 6,052 Total future lease payments $ 17,354 Less: imputed interest (2,300) Present value of lease liabilities $ 15,054 |
Other Income, net
Other Income, net | 6 Months Ended |
Sep. 30, 2023 | |
Other Income and Expenses [Abstract] | |
Other Income, net | Other Income, net Other income, net consisted of the following (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Interest income $ 5,822 $ 1,419 $ 10,840 $ 2,269 Realized gain (loss) on sale and redemption of marketable securities 131 (463) (142) (463) Other income (expense) (50) (48) 44 (94) Other income, net $ 5,903 $ 908 $ 10,742 $ 1,712 |
Income Taxes
Income Taxes | 6 Months Ended |
Sep. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income TaxesThe Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any.The Company’s effective tax rates for the three and six months ended September 30, 2023 were 22.9% and 20.5%, respectively, and for three and six months ended September 30, 2022 were 20.3% and 12.3%, respectively. The Company's effective tax rate differs from the U.S. federal statutory rate, primarily due to state income taxes, stock-based compensation related tax benefits, which are subject to limitations for certain executive officers under IRC section 162(m), and federal and state research and development tax credits. The Company’s effective tax rate is based on forecasted annual income before income taxes which may fluctuate through the rest of the year. The Company is only subject to income taxes in the United States. Significant judgment is required in evaluating the Company’s uncertain tax positions and determining the provision for income taxes. As of September 30, 2023 and March 31, 2023, the Company had unrecognized tax benefits (“UTBs”) of $8.7 million and $7.9 million, respectively. If realized, $6.5 million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months. |
Segment and Geographic Informat
Segment and Geographic Information | 6 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information | Segment and Geographic Information The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company’s performance. As such, the Company has determined that it has one operating and reportable segment. Substantially all of the Company’s long-lived assets were based in the United States as of September 30, 2023 and March 31, 2023. No country outside of the United States accounted for more than 10% of total revenue for the three and six months ended September 30, 2023 and 2022. Substantially all of the Company’s revenue was derived in the United States for the three and six months ended September 30, 2023 and 2022. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent EventsOn October 26, 2023 the Company’s board of directors authorized another program to repurchase up to $70 million of the Company’s Class A common stock. The repurchases are expected to be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock. All prior repurchase programs were completed as of October 2023. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net income | $ 30,602 | $ 26,299 | $ 59,008 | $ 48,682 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended | 6 Months Ended |
Sep. 30, 2023 shares | Sep. 30, 2023 shares | |
Trading Arrangements, by Individual | ||
Non-Rule 10b5-1 Arrangement Adopted | false | |
Rule 10b5-1 Arrangement Terminated | false | |
Non-Rule 10b5-1 Arrangement Terminated | false | |
Ms. Kira Wampler [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On August 24, 2023, Ms. Kira Wampler, a director of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of securities of the Company’s common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Wampler’s Rule 10b5-1 Trading Plan, which has a term from August 24, 2023 to November 29, 2024, provides for the exercise and sale of 37,500 shares of common stock pursuant to a series of market orders. | |
Name | Ms. Kira Wampler | |
Title | director of the Company | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | August 24, 2023 | |
Arrangement Duration | 463 days | |
Aggregate Available | 37,500 | 37,500 |
Ms. Phoebe Yang [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On August 30, 2023, Ms. Phoebe Yang, a director of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Ms. Yang’s Rule 10b5-1 Trading Plan, which has a term from August 30, 2023 to August 14, 2024, provides for the sale of 35% of net vested shares of common stock pursuant to a series of market orders. On the date of the execution of Ms. Yang’s Rule 10b5-1 Trading Plan, Ms. Yang held 2,889 net vested shares. Ms. Yang’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold. | |
Name | Ms. Phoebe Yang | |
Title | director of the Company | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | August 30, 2023 | |
Arrangement Duration | 350 days | |
Aggregate Available | 2,889 | 2,889 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023. |
Principles of Consolidation | The accompanying condensed consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s financial position, results of operations, stockholders’ equity, and cash flows. The results of operations for the three and six months ended September 30, 2023, shown in this report are not necessarily indicative of the results to be expected for the full year ending March 31, 2024. |
Fiscal Year | Fiscal Year The Company’s fiscal year ends on March 31 st . Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year. |
Use of Estimates | Use of Estimates The preparation of the Company’s condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the condensed consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company’s common stock and stock-based awards, fair value of contingent earn-out consideration, and deferred income taxes. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company’s investment strategy is to preserve capital and meet liquidity requirements. The Company’s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking |
Restructuring | Restructuring Restructuring expense primarily consists of severance payments, employee benefits, and stock-based compensation in relation to the modification of equity awards associated with the management-approved plan. One-time employee termination benefits are recognized at the time of communication of the terms of the plan to the employees, unless future service is required, in which case the costs are recognized over the future service period. The Company records these costs in restructuring expense in the condensed consolidated statements of operations. |
Fair Value Measurements | Fair Value Measurements Available-for-sale debt securities are recorded at fair value on the condensed consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1 —Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 —Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 —Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net | The Company’s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows: Revenue Accounts Receivable, Net Three Months Ended September 30, Six Months Ended September 30, September 30, 2023 March 31, 2023 2023 2022 2023 2022 Customer A * * * * 13 % 18 % Customer B * * * * 12 % * _______________ * Less than 10% |
Revenue Recognition (Tables)
Revenue Recognition (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | Revenue consisted of the following (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Subscription $ 106,654 $ 95,333 $ 207,909 $ 179,048 Other 6,958 6,852 14,172 13,776 Total revenue $ 113,612 $ 102,185 $ 222,081 $ 192,824 |
Investments (Tables)
Investments (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments | The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands): As of September 30, 2023 Cost or Gross Gross Fair Value Cash equivalents: Commercial paper $ 9,988 $ — $ (3) $ 9,985 Money market funds 71,842 — — 71,842 Total cash equivalents 81,830 — (3) 81,827 Marketable securities: Asset-backed securities 6,673 1 (12) 6,662 Certificates of deposit 11,965 1 (15) 11,951 Commercial paper 99,773 4 (41) 99,736 Corporate notes and bonds 66,351 1 (266) 66,086 Sovereign bonds 7,746 — (269) 7,477 U.S. government and agency securities 440,905 15 (11,381) 429,539 Total marketable securities 633,413 22 (11,984) 621,451 Total cash equivalents and marketable securities $ 715,243 $ 22 $ (11,987) $ 703,278 The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands): As of March 31, 2023 Cost or Gross Gross Fair Value Cash equivalents: Money market funds $ 126,275 $ — $ — $ 126,275 Total cash equivalents 126,275 — — 126,275 Marketable securities: Asset-backed securities 7,271 — (71) 7,200 Certificates of deposit 27,380 — (80) 27,300 Commercial paper 78,609 6 (126) 78,489 Corporate notes and bonds 119,241 49 (778) 118,512 Sovereign bonds 7,744 — (360) 7,384 U.S. government and agency securities 461,584 12 (17,509) 444,087 Total marketable securities 701,829 67 (18,924) 682,972 Total cash equivalents and marketable securities $ 828,104 $ 67 $ (18,924) $ 809,247 |
Contractual Maturities of Available-For-Sale Debt Securities | As of September 30, 2023, the contractual maturities of the Company’s available-for-sale debt securities were as follows (in thousands): Fair Value Due within one year $ 583,534 Due in one to two years 41,240 Asset-backed securities 6,662 Total $ 631,436 |
Gross Unrealized Losses and Fair Values of Investments in an Unrealized Loss Position | The following tables summarize the gross unrealized losses and fair values of investments in an unrealized loss position, aggregated by security type and length of time that the individual securities have been in a continuous unrealized loss position (in thousands): As of September 30, 2023 Less than 12 months 12 months or greater Total Fair Value Gross Fair Value Gross Fair Value Gross Asset-backed securities $ 4,569 $ (8) $ 1,018 $ (4) $ 5,587 $ (12) Certificates of deposit 11,006 (15) — — 11,006 (15) Commercial paper 96,131 (44) — — 96,131 (44) Corporate notes and bonds 55,618 (139) 6,241 (127) 61,859 (266) Sovereign bonds — — 7,477 (269) 7,477 (269) U.S. government and agency securities 42,925 (75) 362,967 (11,306) 405,892 (11,381) Total $ 210,249 $ (281) $ 377,703 $ (11,706) $ 587,952 $ (11,987) As of March 31, 2023 Less than 12 months 12 months or greater Total Fair Value Gross Fair Value Gross Fair Value Gross Asset-backed securities $ 2,601 $ (12) $ 4,599 $ (59) $ 7,200 $ (71) Certificates of deposit 27,018 (80) — — 27,018 (80) Commercial paper 70,681 (126) — — 70,681 (126) Corporate notes and bonds 42,575 (113) 58,766 (665) 101,341 (778) Sovereign bonds — — 7,384 (360) 7,384 (360) U.S. government and agency securities — — 439,748 (17,509) 439,748 (17,509) Total $ 142,875 $ (331) $ 510,497 $ (18,593) $ 653,372 $ (18,924) |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value, Assets Measured on Recurring Basis | The following tables present the fair value hierarchy for the Company’s assets and liabilities measured at fair value on a recurring basis (in thousands): As of September 30, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Commercial paper $ — $ 9,985 $ — $ 9,985 Money market funds 71,842 — — 71,842 Total cash equivalents 71,842 9,985 — 81,827 Marketable securities: Asset-backed securities — 6,662 — 6,662 Certificates of deposit — 11,951 — 11,951 Commercial paper — 99,736 — 99,736 Corporate notes and bonds — 66,086 — 66,086 Sovereign bonds — 7,477 — 7,477 U.S. government and agency securities 415,280 14,259 — 429,539 Total marketable securities 415,280 206,171 — 621,451 Total cash equivalents and marketable securities $ 487,122 $ 216,156 $ — $ 703,278 Liabilities: Contingent earn-out consideration liability $ — $ — $ 16,178 $ 16,178 Total contingent earn-out consideration liability $ — $ — $ 16,178 $ 16,178 As of March 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 126,275 $ — $ — $ 126,275 Total cash equivalents 126,275 — — 126,275 Marketable securities: Asset-backed securities — 7,200 — 7,200 Certificates of deposit — 27,300 — 27,300 Commercial paper — 78,489 — 78,489 Corporate notes and bonds — 118,512 — 118,512 Sovereign bonds — 7,384 — 7,384 U.S. government and agency securities 439,748 4,339 — 444,087 Total marketable securities 439,748 243,224 — 682,972 Total cash equivalents and marketable securities $ 566,023 $ 243,224 $ — $ 809,247 Liabilities: Contingent earn-out consideration liability $ — $ — $ 21,862 $ 21,862 Total contingent earn-out consideration liability $ — $ — $ 21,862 $ 21,862 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following table summarizes the changes in the contingent earn-out consideration liability (in thousands): Six Months Ended September 30, 2023 2022 Beginning fair value $ 21,862 $ — Additions in the period — 21,134 Change in fair value 316 (94) Payments (6,000) — Ending fair value $ 16,178 $ 21,040 |
Property and Equipment, Net (Ta
Property and Equipment, Net (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment, Net | Property and equipment, net consisted of the following (in thousands): September 30, 2023 March 31, 2023 Furniture and equipment $ 2,846 $ 2,816 Computers and software 745 745 Leasehold improvements 982 888 Internal-use software development costs 23,366 20,405 Total property and equipment 27,939 24,854 Less: accumulated depreciation and amortization (16,159) (13,575) Total property and equipment, net $ 11,780 $ 11,279 |
Accrued Expenses and Other Cu_2
Accrued Expenses and Other Current Liabilities (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands): September 30, 2023 March 31, 2023 Accrued commissions $ 3,570 $ 5,733 Accrued payroll, bonus, and related expenses 7,444 8,739 Employee contributions under employee stock purchase plan 529 589 Rebate liabilities 681 3,348 Sales and other tax liabilities 2,210 1,504 Current portion of contingent earn-out consideration liability 5,730 5,920 Restructuring liability 541 — Share repurchase liability 5,003 748 Other 3,378 4,664 Total accrued expenses and other current liabilities $ 29,086 $ 31,245 |
Business Combinations (Tables)
Business Combinations (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Purchase Consideration Allocation | The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands): Assets acquired: Accounts receivable $ 447 Customer relationships 27,200 Developed technology 820 Trademark 700 Total assets acquired $ 29,167 Liabilities assumed: Deferred revenue $ 2,925 Other liabilities 633 Net assets acquired, excluding goodwill 25,609 Goodwill $ 49,025 Total purchase consideration $ 74,634 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets, Net | Intangible assets, net consisted of the following (in thousands): September 30, 2023 March 31, 2023 Customer relationships $ 37,069 $ 37,069 Other intangibles 1,531 1,531 Total intangible assets 38,600 38,600 Less: accumulated amortization (9,160) (6,764) Total intangible assets, net $ 29,440 $ 31,836 |
Future Amortization Expense | As of September 30, 2023, future amortization expense is as follows (in thousands): Year Ending March 31, Amount Remainder of 2024 $ 2,123 2025 4,245 2026 4,012 2027 4,010 2028 4,010 2029 4,010 Thereafter 7,030 Total future amortization expense $ 29,440 |
Equity (Tables)
Equity (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Common Stock Reserved for Issuance | The Company has shares of common stock reserved for issuance as follows (in thousands): September 30, 2023 Common stock warrants 641 2010 Plan Options outstanding 16,664 2021 Plan Awards outstanding 2,159 Shares available for future grant 41,195 2021 ESPP 8,104 Options outstanding outside the plans 2,655 Total 71,418 |
Stock Option Activity | Stock option activities within the Plans as well as outside of the Plans were as follows: Number of Shares Weighted-Average Average Remaining Contractual Term Aggregate Intrinsic Value (in thousands) Balance, March 31, 2023 22,407 $ 4.39 6.56 $ 627,187 Options exercised (2,380) 3.05 Options forfeited or expired (708) 5.47 Balance, September 30, 2023 19,319 4.51 6.12 322,735 Vested and exercisable as of September 30, 2023 11,804 2.93 5.40 215,941 Vested and expected to vest as of September 30, 2023 18,740 4.44 6.09 314,519 |
Restricted Stock Unit Activity | The following table summarizes RSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2023 1,951 $ 40.08 Granted 749 30.02 Vested (392) 38.44 Forfeited (372) 44.59 Unvested balance, September 30, 2023 1,936 35.46 |
Performance-Based Stock Unit Activity | The following table summarizes PSU activity (in thousands, except per share information): Number of Shares Weighted- Unvested balance, March 31, 2023 206 $ 34.68 Granted 156 33.74 Vested (78) 36.96 Forfeited (61) 35.07 Unvested balance, September 30, 2023 223 33.10 |
Stock-Based Compensation Expense | Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Cost of revenue $ 2,278 $ 2,392 $ 4,739 $ 4,514 Research and development 2,538 2,862 5,794 5,414 Sales and marketing 2,697 3,982 8,692 7,056 General and administrative 2,288 2,117 4,577 3,875 Restructuring 3,646 — 3,646 — Total stock-based compensation expense $ 13,447 $ 11,353 $ 27,448 $ 20,859 |
Net Income Per Share Attribut_2
Net Income Per Share Attributable to Common Stockholders (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Net Income Per Share, Basic and Diluted | The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Numerator Net income $ 30,602 $ 26,299 $ 59,008 $ 48,682 Denominator Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic 193,112 193,137 193,813 193,042 Dilutive effect of stock options 15,673 20,595 16,573 21,178 Dilutive effect of common stock warrants 122 123 122 155 Dilutive effect of other share-based awards 107 94 173 77 Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted 209,014 213,949 210,681 214,452 Net income per share attributable to Class A and Class B common stockholders: Basic $ 0.16 $ 0.14 $ 0.30 $ 0.25 Diluted $ 0.15 $ 0.12 $ 0.28 $ 0.23 |
Antidilutive Securities Excluded from Computation of Net Income Per Share | Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Other share-based awards 1,665 511 911 512 Common stock warrants 516 516 516 516 Total 2,181 1,027 1,427 1,028 |
Restructuring (Tables)
Restructuring (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Activities Related to the Restructuring | The following table summarizes the activities related to the Restructuring Plan as of September 30, 2023 (in thousands): Workforce Reduction Liability as of July 1, 2023 $ — Charges 4,289 Payments (3,748) Liability as of September 30, 2023 $ 541 |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases | The components of lease expense were as follows (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 701 $ 701 $ 1,402 $ 1,190 Variable lease cost 45 133 65 173 Total lease cost $ 746 $ 834 $ 1,467 $ 1,363 Supplemental cash flow information related to leases was as follows (in thousands): Six Months Ended September 30, 2023 2022 Cash paid for amounts included in measurement of lease liabilities—Operating cash flows $ 907 $ 389 Supplemental balance sheet information related to leases was as follows: September 30, 2023 March 31, 2023 Weighted-average remaining lease term (in years) 6.68 7.06 Weighted-average discount rate 4.19 % 4.18 % |
Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities as of September 30, 2023 were as follows (in thousands): Remainder of 2024 $ 1,331 2025 2,411 2026 2,458 2027 2,497 2028 2,605 Thereafter 6,052 Total future lease payments $ 17,354 Less: imputed interest (2,300) Present value of lease liabilities $ 15,054 |
Other Income, net (Tables)
Other Income, net (Tables) | 6 Months Ended |
Sep. 30, 2023 | |
Other Income and Expenses [Abstract] | |
Other Income, Net | Other income, net consisted of the following (in thousands): Three Months Ended September 30, Six Months Ended September 30, 2023 2022 2023 2022 Interest income $ 5,822 $ 1,419 $ 10,840 $ 2,269 Realized gain (loss) on sale and redemption of marketable securities 131 (463) (142) (463) Other income (expense) (50) (48) 44 (94) Other income, net $ 5,903 $ 908 $ 10,742 $ 1,712 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details) - Customer Concentration Risk - Accounts Receivable, Net | 6 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Mar. 31, 2023 | |
Customer A | ||
Concentration Risk [Line Items] | ||
Concentration risk | 13% | 18% |
Customer B | ||
Concentration Risk [Line Items] | ||
Concentration risk | 12% |
Revenue Recognition - Narrative
Revenue Recognition - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | |||||
Unbilled revenue | $ 1,800,000 | $ 1,800,000 | $ 2,200,000 | ||
Deferred revenue expected to be recognized, period (within) | 12 months | ||||
Revenue recognized from deferred revenue | 71,400,000 | $ 64,300,000 | $ 97,100,000 | $ 75,600,000 | |
Capitalized contract acquisition costs | 1,200,000 | 1,500,000 | 2,400,000 | 2,300,000 | |
Deferred contract costs, amortization | 2,000,000 | 2,100,000 | 4,730,000 | 4,839,000 | |
Deferred contract costs, impairment losses | $ 0 | $ 0 | $ 0 | $ 0 | |
Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts | Minimum | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 7 months | 7 months | |||
Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts | Maximum | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 14 months | 14 months | |||
Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts | |||||
Disaggregation of Revenue [Line Items] | |||||
Deferred contract costs, amortization period | 4 years | 4 years | |||
Subscription, Marketing Solutions | |||||
Disaggregation of Revenue [Line Items] | |||||
Contractual term | 12 months | ||||
Subscription, Hiring Solutions | |||||
Disaggregation of Revenue [Line Items] | |||||
Contractual term | 12 months |
Revenue Recognition - Disaggreg
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 113,612 | $ 102,185 | $ 222,081 | $ 192,824 |
Subscription | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | 106,654 | 95,333 | 207,909 | 179,048 |
Other | ||||
Disaggregation of Revenue [Line Items] | ||||
Revenue | $ 6,958 | $ 6,852 | $ 14,172 | $ 13,776 |
Investments - Cost, Gross Unrea
Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Gains | $ 22 | $ 67 |
Gross Unrealized Losses | (11,987) | (18,924) |
Fair Value | 631,436 | |
Cost or Amortized Cost, money market funds | 108,403 | 158,027 |
Cost or Amortized Cost, cash equivalents and marketable securities | 715,243 | 828,104 |
Fair Value, cash equivalents and marketable securities | 703,278 | 809,247 |
Cash and Cash Equivalents | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (3) | 0 |
Fair Value | 81,827 | |
Cost or Amortized Cost, cash equivalents and marketable securities | 81,830 | 126,275 |
Fair Value, cash equivalents and marketable securities | 126,275 | |
Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 633,413 | 701,829 |
Gross Unrealized Gains | 22 | 67 |
Gross Unrealized Losses | (11,984) | (18,924) |
Fair Value | 621,451 | 682,972 |
Commercial paper | Cash and Cash Equivalents | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 9,988 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (3) | |
Fair Value | 9,985 | |
Money market funds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost, money market funds | 71,842 | 126,275 |
Fair Value, money market funds | 71,842 | 126,275 |
Asset-backed securities | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 6,673 | 7,271 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | (12) | (71) |
Fair Value | 6,662 | 7,200 |
Certificates of deposit | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 11,965 | 27,380 |
Gross Unrealized Gains | 1 | 0 |
Gross Unrealized Losses | (15) | (80) |
Fair Value | 11,951 | 27,300 |
Commercial paper | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 99,773 | 78,609 |
Gross Unrealized Gains | 4 | 6 |
Gross Unrealized Losses | (41) | (126) |
Fair Value | 99,736 | 78,489 |
Corporate notes and bonds | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 66,351 | 119,241 |
Gross Unrealized Gains | 1 | 49 |
Gross Unrealized Losses | (266) | (778) |
Fair Value | 66,086 | 118,512 |
Sovereign bonds | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 7,746 | 7,744 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (269) | (360) |
Fair Value | 7,477 | 7,384 |
U.S. government and agency securities | Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost or Amortized Cost | 440,905 | 461,584 |
Gross Unrealized Gains | 15 | 12 |
Gross Unrealized Losses | (11,381) | (17,509) |
Fair Value | $ 429,539 | $ 444,087 |
Investments - Contractual Matur
Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details) $ in Thousands | Sep. 30, 2023 USD ($) |
Investments, Debt and Equity Securities [Abstract] | |
Due within one year | $ 583,534 |
Due in one to two years | 41,240 |
Asset-backed securities | 6,662 |
Total | $ 631,436 |
Investments - Narrative (Detail
Investments - Narrative (Details) - USD ($) | Sep. 30, 2023 | Mar. 31, 2023 |
Debt Securities, Available-for-sale [Line Items] | ||
Accrued interest | $ 2,500,000 | $ 2,800,000 |
Unrealized losses of debt securities | 11,987,000 | 18,924,000 |
Impairment on debt securities | 0 | 0 |
Debt securities credit losses | 0 | 0 |
Fair value of debt securities which no credit losses were recognized | 587,952,000 | 653,372,000 |
Marketable Securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Unrealized losses of debt securities | $ 11,984,000 | $ 18,924,000 |
Investments - Gross Unrealized
Investments - Gross Unrealized Losses and Fair Values of Investments in an Unrealized Loss Position (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Fair Value | ||
Less than 12 months | $ 210,249 | $ 142,875 |
12 months or greater | 377,703 | 510,497 |
Total, fair value | 587,952 | 653,372 |
Gross Unrealized Losses | ||
Less than 12 months | (281) | (331) |
12 months or greater | (11,706) | (18,593) |
Total, unrealized losses | (11,987) | (18,924) |
Asset-backed securities | ||
Fair Value | ||
Less than 12 months | 4,569 | 2,601 |
12 months or greater | 1,018 | 4,599 |
Total, fair value | 5,587 | 7,200 |
Gross Unrealized Losses | ||
Less than 12 months | (8) | (12) |
12 months or greater | (4) | (59) |
Total, unrealized losses | (12) | (71) |
Certificates of deposit | ||
Fair Value | ||
Less than 12 months | 11,006 | 27,018 |
12 months or greater | 0 | 0 |
Total, fair value | 11,006 | 27,018 |
Gross Unrealized Losses | ||
Less than 12 months | (15) | (80) |
12 months or greater | 0 | 0 |
Total, unrealized losses | (15) | (80) |
Commercial paper | ||
Fair Value | ||
Less than 12 months | 96,131 | 70,681 |
12 months or greater | 0 | 0 |
Total, fair value | 96,131 | 70,681 |
Gross Unrealized Losses | ||
Less than 12 months | (44) | (126) |
12 months or greater | 0 | 0 |
Total, unrealized losses | (44) | (126) |
Corporate notes and bonds | ||
Fair Value | ||
Less than 12 months | 55,618 | 42,575 |
12 months or greater | 6,241 | 58,766 |
Total, fair value | 61,859 | 101,341 |
Gross Unrealized Losses | ||
Less than 12 months | (139) | (113) |
12 months or greater | (127) | (665) |
Total, unrealized losses | (266) | (778) |
Sovereign bonds | ||
Fair Value | ||
Less than 12 months | 0 | 0 |
12 months or greater | 7,477 | 7,384 |
Total, fair value | 7,477 | 7,384 |
Gross Unrealized Losses | ||
Less than 12 months | 0 | 0 |
12 months or greater | (269) | (360) |
Total, unrealized losses | (269) | (360) |
U.S. government and agency securities | ||
Fair Value | ||
Less than 12 months | 42,925 | 0 |
12 months or greater | 362,967 | 439,748 |
Total, fair value | 405,892 | 439,748 |
Gross Unrealized Losses | ||
Less than 12 months | (75) | 0 |
12 months or greater | (11,306) | (17,509) |
Total, unrealized losses | $ (11,381) | $ (17,509) |
Fair Value Measurements - Asset
Fair Value Measurements - Assets and Liabilities at Fair Value (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | $ 631,436 | |
Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 81,827 | |
Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 621,451 | $ 682,972 |
Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 9,985 | |
Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,662 | 7,200 |
Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 11,951 | 27,300 |
Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 99,736 | 78,489 |
Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 66,086 | 118,512 |
Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,477 | 7,384 |
U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 429,539 | 444,087 |
Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 703,278 | 809,247 |
Liabilities: | ||
Contingent earn-out consideration liability | 16,178 | 21,862 |
Total contingent earn-out consideration liability | 16,178 | 21,862 |
Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 81,827 | 126,275 |
Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 621,451 | 682,972 |
Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 9,985 | |
Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 71,842 | 126,275 |
Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,662 | 7,200 |
Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 11,951 | 27,300 |
Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 99,736 | 78,489 |
Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 66,086 | 118,512 |
Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,477 | 7,384 |
Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 429,539 | 444,087 |
Level 1 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 487,122 | 566,023 |
Liabilities: | ||
Contingent earn-out consideration liability | 0 | 0 |
Total contingent earn-out consideration liability | 0 | 0 |
Level 1 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 71,842 | 126,275 |
Level 1 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 415,280 | 439,748 |
Level 1 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | |
Level 1 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 71,842 | 126,275 |
Level 1 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 1 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 415,280 | 439,748 |
Level 2 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 216,156 | 243,224 |
Liabilities: | ||
Contingent earn-out consideration liability | 0 | 0 |
Total contingent earn-out consideration liability | 0 | 0 |
Level 2 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 9,985 | 0 |
Level 2 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 206,171 | 243,224 |
Level 2 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 9,985 | |
Level 2 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 2 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 6,662 | 7,200 |
Level 2 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 11,951 | 27,300 |
Level 2 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 99,736 | 78,489 |
Level 2 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 66,086 | 118,512 |
Level 2 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 7,477 | 7,384 |
Level 2 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 14,259 | 4,339 |
Level 3 | Fair Value, Recurring | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Liabilities: | ||
Contingent earn-out consideration liability | 16,178 | 21,862 |
Total contingent earn-out consideration liability | 16,178 | 21,862 |
Level 3 | Fair Value, Recurring | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Commercial paper | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | |
Level 3 | Fair Value, Recurring | Money market funds | Cash and Cash Equivalents | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Asset-backed securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Certificates of deposit | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Commercial paper | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Corporate notes and bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | Sovereign bonds | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | 0 | 0 |
Level 3 | Fair Value, Recurring | U.S. government and agency securities | Marketable Securities | ||
Assets, Fair Value Disclosure [Abstract] | ||
Cash equivalents and marketable securities | $ 0 | $ 0 |
Fair Value Measurements - Conti
Fair Value Measurements - Contingent Earn-Out Consideration Liability (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Beginning fair value | $ 21,862 | $ 0 |
Additions in the period | 0 | 21,134 |
Change in fair value | 316 | (94) |
Payments | (6,000) | 0 |
Ending fair value | $ 16,178 | $ 21,040 |
Property and Equipment, Net - T
Property and Equipment, Net - Total Property and Equipment, Net (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 27,939 | $ 24,854 |
Less: accumulated depreciation and amortization | (16,159) | (13,575) |
Total property and equipment, net | 11,780 | 11,279 |
Furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 2,846 | 2,816 |
Computers and software | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 745 | 745 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | 982 | 888 |
Internal-use software development costs | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, gross | $ 23,366 | $ 20,405 |
Property and Equipment, Net - N
Property and Equipment, Net - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation and amortization expense | $ 1,400,000 | $ 1,400,000 | $ 2,800,000 | $ 2,600,000 |
Amortization of internal-use software development costs | 1,200,000 | 1,200,000 | 2,400,000 | 2,300,000 |
Capitalized internal-use software development costs | 1,500,000 | 1,200,000 | 3,300,000 | 2,900,000 |
Impairment charges | $ 0 | $ 0 | $ 0 | $ 0 |
Accrued Expenses and Other Cu_3
Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Payables and Accruals [Abstract] | ||
Accrued commissions | $ 3,570 | $ 5,733 |
Accrued payroll, bonus, and related expenses | 7,444 | 8,739 |
Employee contributions under employee stock purchase plan | 529 | 589 |
Rebate liabilities | 681 | 3,348 |
Sales and other tax liabilities | 2,210 | 1,504 |
Current portion of contingent earn-out consideration liability | 5,730 | 5,920 |
Restructuring liability | 541 | 0 |
Share repurchase liability | 5,003 | 748 |
Other | 3,378 | 4,664 |
Total accrued expenses and other current liabilities | $ 29,086 | $ 31,245 |
Business Combinations - Narrati
Business Combinations - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended | |
Apr. 01, 2022 | May 31, 2022 | Sep. 30, 2023 | Sep. 30, 2023 | |
Restricted Stock Units (RSUs) | ||||
Business Acquisition [Line Items] | ||||
Other than options granted in period (in shares) | 749,000 | |||
Granted (in dollars per share) | $ 30.02 | |||
Award vesting period | 4 years | |||
AMiON | ||||
Business Acquisition [Line Items] | ||||
Consideration transferred | $ 74.6 | |||
Payments to acquire businesses | 53.5 | |||
Contingent earn-out consideration liability | 21.1 | |||
Contingent earn-out consideration (up to) | 24 | |||
Contingent earn-out consideration liability, minimum guarantee | 4 | |||
Contingent earn-out consideration liability, subject to performance | $ 20 | |||
Contingent earnout consideration performance period | 4 years | |||
Contingent earnout consideration payable period | 4 years | |||
Contingent consideration liability settled | $ 6 | |||
Award vesting period | 4 years | |||
AMiON | Restricted Stock Units (RSUs) | ||||
Business Acquisition [Line Items] | ||||
Other than options granted in period (in shares) | 93,458 | |||
Granted (in dollars per share) | $ 32.99 | |||
AMiON | Customer relationships | ||||
Business Acquisition [Line Items] | ||||
Finite-lived intangibles, useful life | 9 years | |||
AMiON | Trademark | ||||
Business Acquisition [Line Items] | ||||
Finite-lived intangibles, useful life | 3 years | |||
AMiON | Developed technology | ||||
Business Acquisition [Line Items] | ||||
Finite-lived intangibles, useful life | 18 months |
Business Combinations - Purchas
Business Combinations - Purchase Consideration Allocation (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 | Apr. 01, 2022 |
Liabilities assumed: | |||
Goodwill | $ 67,940 | $ 67,940 | |
AMiON | |||
Assets acquired: | |||
Accounts receivable | $ 447 | ||
Total assets acquired | 29,167 | ||
Liabilities assumed: | |||
Deferred revenue | 2,925 | ||
Other liabilities | 633 | ||
Net assets acquired, excluding goodwill | 25,609 | ||
Goodwill | 49,025 | ||
Total purchase consideration | 74,634 | ||
AMiON | Customer relationships | |||
Assets acquired: | |||
Finite-lived intangibles | 27,200 | ||
AMiON | Developed technology | |||
Assets acquired: | |||
Finite-lived intangibles | 820 | ||
AMiON | Trademark | |||
Assets acquired: | |||
Finite-lived intangibles | $ 700 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill - Intangible Assets, Net (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 38,600 | $ 38,600 |
Less: accumulated amortization | (9,160) | (6,764) |
Intangible assets, net | 29,440 | 31,836 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | 37,069 | 37,069 |
Other intangibles | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets, gross | $ 1,531 | $ 1,531 |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of intangible assets | $ 1,200,000 | $ 1,200,000 | $ 2,400,000 | $ 2,400,000 |
Impairment of intangible assets | 0 | 0 | 0 | 0 |
Goodwill impairment | $ 0 | $ 0 | $ 0 | $ 0 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill - Future Amortization Expense (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Mar. 31, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Remainder of 2024 | $ 2,123 | |
2025 | 4,245 | |
2026 | 4,012 | |
2027 | 4,010 | |
2028 | 4,010 | |
2029 | 4,010 | |
Thereafter | 7,030 | |
Intangible assets, net | $ 29,440 | $ 31,836 |
Equity - Narrative (Details)
Equity - Narrative (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 5 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||||||
Jun. 01, 2023 USD ($) | Oct. 28, 2022 USD ($) | Jun. 08, 2021 vote $ / shares shares | Oct. 31, 2021 USD ($) $ / shares Year shares | Sep. 30, 2023 USD ($) equityIncentivePlan $ / shares shares | Sep. 30, 2022 USD ($) | Sep. 30, 2022 USD ($) shares | Sep. 30, 2023 USD ($) equityIncentivePlan $ / shares shares | Sep. 30, 2022 USD ($) shares | Sep. 30, 2023 USD ($) equityIncentivePlan $ / shares shares | Mar. 31, 2018 shares | Mar. 31, 2023 $ / shares shares | May 12, 2022 USD ($) | Jun. 30, 2021 $ / shares shares | Mar. 31, 2017 $ / shares shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Preferred stock, authorized (in shares) | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | ||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||
Preferred stock, issued (in shares) | 0 | 0 | 0 | 0 | |||||||||||
Preferred stock, outstanding (in shares) | 0 | 0 | 0 | 0 | |||||||||||
Common stock, authorized (in shares) | 1,500,000,000 | 1,500,000,000 | 1,500,000,000 | 1,500,000,000 | |||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||
Common stock, outstanding (in shares) | 188,518,000 | 188,518,000 | 188,518,000 | 193,941,000 | |||||||||||
Stock repurchase program, authorized amount | $ | $ 200,000 | $ 70,000 | $ 70,000 | ||||||||||||
Stock repurchase program, period in force | 24 months | 12 months | |||||||||||||
Repurchase and retirement of common stock (in shares) | 2,150,982 | 8,723,200 | |||||||||||||
Repurchase and retirement of common stock | $ | $ 170,363 | $ 61,168 | $ 70,000 | $ 191,468 | $ 70,042 | $ 207,500 | |||||||||
Stock repurchase program, remaining authorized repurchase amount | $ | 63,700 | 63,700 | 63,700 | ||||||||||||
Repurchase and retirement of common stock, commissions and excise taxes | $ | $ 1,200 | $ 1,200 | $ 1,200 | ||||||||||||
Number of shares called by warrants | 641,000 | 641,000 | 641,000 | ||||||||||||
Stock based compensation expense | $ | $ 13,447 | $ 11,353 | $ 27,448 | 20,859 | |||||||||||
Number of equity incentive plans | equityIncentivePlan | 3 | 3 | 3 | ||||||||||||
Options outstanding in period (in shares) | 19,319,000 | 19,319,000 | 19,319,000 | 22,407,000 | |||||||||||
Aggregate intrinsic value of options | $ | $ 61,800 | 60,200 | |||||||||||||
Unamortized compensation expense, option | $ | $ 27,600 | $ 27,600 | $ 27,600 | ||||||||||||
Stock options | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Unamortized compensation expense, weighted average period of recognition | 2 years 9 months 7 days | ||||||||||||||
Award vesting period | 4 years | ||||||||||||||
Expiration period from the date of grant | 10 years | ||||||||||||||
Restricted Stock Units (RSUs) | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Unamortized stock-based compensation expense excluding option | $ | 54,300 | $ 54,300 | 54,300 | ||||||||||||
Unamortized compensation expense, weighted average period of recognition | 2 years 11 months 26 days | ||||||||||||||
Award vesting period | 4 years | ||||||||||||||
Total fair value of non-option instrument | $ | $ 11,300 | 3,300 | |||||||||||||
Performance-Based Restricted Stock Units | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Unamortized stock-based compensation expense excluding option | $ | $ 1,900 | $ 1,900 | $ 1,900 | ||||||||||||
Unamortized compensation expense, weighted average period of recognition | 1 year 6 months 14 days | ||||||||||||||
Total fair value of non-option instrument | $ | $ 1,800 | $ 400 | |||||||||||||
Approved by Board of Directors, Outside of Plans | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Options granted in period (in shares) | 4,682,582 | ||||||||||||||
Options exercised (in shares) | 2,027,917 | 2,027,917 | 2,027,917 | ||||||||||||
Options outstanding in period (in shares) | 2,654,665 | 2,654,665 | 2,654,665 | ||||||||||||
Contract With U.S. News & World Report, L.P. | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Number of shares called by warrants | 250,000 | ||||||||||||||
Exercise price called by warrants (in dollars per share) | $ / shares | $ 0.72 | ||||||||||||||
Warrant outstanding, term | 10 years | ||||||||||||||
Warrants exercised in period (in shares) | 0 | 125,000 | |||||||||||||
Warrants exercised in period , intrinsic value | $ | $ 4,000 | ||||||||||||||
Warrant outstanding (in shares) | 125,000 | 125,000 | 125,000 | ||||||||||||
U.S. News Warrant | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Number of shares called by warrants | 516,000 | ||||||||||||||
Exercise price called by warrants (in dollars per share) | $ / shares | $ 12.56 | ||||||||||||||
Warrant outstanding, term | 10 years | ||||||||||||||
Warrants outstanding, vesting period | 6 years 5 months 23 days | ||||||||||||||
Fair value of warrant | $ | $ 34,700 | ||||||||||||||
Stock based compensation expense | $ | $ 2,700 | $ 2,700 | |||||||||||||
Unamortized stock-based compensation expense excluding option | $ | $ 24,100 | $ 24,100 | $ 24,100 | ||||||||||||
Unamortized compensation expense, weighted average period of recognition | 4 years 6 months | ||||||||||||||
U.S. News Warrant | Share-Based Payment Arrangement, Subsequent to Tranche One | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrants outstanding, vesting period | 6 years | ||||||||||||||
U.S. News Warrant | Measurement Input, Share Price | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrant, measurement input | $ / shares | 76.50 | ||||||||||||||
U.S. News Warrant | Measurement Input, Price Volatility | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrant, measurement input | 0.469 | ||||||||||||||
U.S. News Warrant | Measurement Input, Risk Free Interest Rate | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrant, measurement input | 0.0161 | ||||||||||||||
U.S. News Warrant | Measurement Input, Expected Term | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrant, measurement input | Year | 10 | ||||||||||||||
U.S. News Warrant | Measurement Input, Expected Dividend Rate | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Warrant, measurement input | 0 | ||||||||||||||
Class A and Class B Common Stock | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Conversion of stock (in shares) | 85,523,836 | ||||||||||||||
Common Class A | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Common stock, authorized (in shares) | 1,000,000,000 | ||||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | ||||||||||||||
Common stock, number of votes per share | vote | 1 | ||||||||||||||
Common stock, outstanding (in shares) | 120,768,274 | 120,768,274 | 120,768,274 | ||||||||||||
Common Class B | |||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||||
Common stock, authorized (in shares) | 500,000,000 | ||||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.001 | ||||||||||||||
Common stock, number of votes per share | vote | 10 | ||||||||||||||
Conversion of stock, conversion ratio | 1 | ||||||||||||||
Common stock, outstanding (in shares) | 67,750,282 | 67,750,282 | 67,750,282 |
Equity - Common Stock Reserved
Equity - Common Stock Reserved for Issuance (Details) - shares | Sep. 30, 2023 | Mar. 31, 2023 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Common stock warrants (in shares) | 641,000 | |
Options outstanding (in shares) | 19,319,000 | 22,407,000 |
Total (in shares) | 71,418,000 | |
2010 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options outstanding (in shares) | 16,664,000 | |
2021 Plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares available for future grant (in shares) | 41,195,000 | |
Units outstanding (in shares) | 2,159,000 | |
2021 ESPP | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares available for future grant (in shares) | 8,104,000 | |
Options outstanding outside the plans | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Options outstanding (in shares) | 2,654,665 |
Equity - Stock Option Activity
Equity - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended | 12 Months Ended |
Sep. 30, 2023 USD ($) $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | |
Number of Shares (in thousands) | ||
Beginning balance (in shares) | shares | 22,407 | |
Options exercised (in shares) | shares | (2,380) | |
Options forfeited or expired (in shares) | shares | (708) | |
Ending balance (in shares) | shares | 19,319 | 22,407 |
Vested and exercisable, at end of period (in shares) | shares | 11,804 | |
Vested and expected to vest, at end of period (in shares) | shares | 18,740 | |
Weighted-Average Exercise Price | ||
Beginning balance (in dollars per share) | $ / shares | $ 4.39 | |
Exercised (in dollars per share) | $ / shares | 3.05 | |
Forfeited or expired (in dollars per share) | $ / shares | 5.47 | |
Ending balance (in dollars per share) | $ / shares | 4.51 | $ 4.39 |
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares | 2.93 | |
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares | $ 4.44 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ||
Average remaining contractual term, outstanding | 6 years 1 month 13 days | 6 years 6 months 21 days |
Average remaining contractual term, vested and exercisable at period end | 5 years 4 months 24 days | |
Average remaining contractual term, vested and expected to vest at period end | 6 years 1 month 2 days | |
Aggregate intrinsic value, outstanding | $ | $ 322,735 | $ 627,187 |
Aggregate intrinsic value, vested and exercisable at period end | $ | 215,941 | |
Aggregate intrinsic value, vested and expected to vest at period end | $ | $ 314,519 |
Equity - Restricted Stock Unit
Equity - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) shares in Thousands | 6 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Number of Shares | |
Beginning balance (in shares) | shares | 1,951 |
Granted (in shares) | shares | 749 |
Vested (in shares) | shares | (392) |
Forfeited (in shares) | shares | (372) |
Ending balance (in shares) | shares | 1,936 |
Weighted- Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 40.08 |
Granted (in dollars per share) | $ / shares | 30.02 |
Vested (in dollars per share) | $ / shares | 38.44 |
Forfeited (in dollars per share) | $ / shares | 44.59 |
Ending balance (in dollars per share) | $ / shares | $ 35.46 |
Equity - Performance-Based Stoc
Equity - Performance-Based Stock Unit Activity (Details) - Performance-Based Restricted Stock Units shares in Thousands | 6 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Number of Shares | |
Beginning balance (in shares) | shares | 206 |
Granted (in shares) | shares | 156 |
Vested (in shares) | shares | (78) |
Forfeited (in shares) | shares | (61) |
Ending balance (in shares) | shares | 223 |
Weighted- Average Grant Date Fair Value | |
Beginning balance (in dollars per share) | $ / shares | $ 34.68 |
Granted (in dollars per share) | $ / shares | 33.74 |
Vested (in dollars per share) | $ / shares | 36.96 |
Forfeited (in dollars per share) | $ / shares | 35.07 |
Ending balance (in dollars per share) | $ / shares | $ 33.10 |
Equity - Stock-Based Compensati
Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | $ 13,447 | $ 11,353 | $ 27,448 | $ 20,859 |
Cost of revenue | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 2,278 | 2,392 | 4,739 | 4,514 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 2,538 | 2,862 | 5,794 | 5,414 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 2,697 | 3,982 | 8,692 | 7,056 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | 2,288 | 2,117 | 4,577 | 3,875 |
Restructuring | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Stock based compensation expense | $ 3,646 | $ 0 | $ 3,646 | $ 0 |
Net Income Per Share Attribut_3
Net Income Per Share Attributable to Common Stockholders - Net Income Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Numerator | ||||
Net income | $ 30,602 | $ 26,299 | $ 59,008 | $ 48,682 |
Denominator | ||||
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares) | 193,112 | 193,137 | 193,813 | 193,042 |
Dilutive effect of common stock warrants (in shares) | 122 | 123 | 122 | 155 |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares) | 209,014 | 213,949 | 210,681 | 214,452 |
Net income per share attributable to Class A and Class B common stockholders: | ||||
Basic (in dollars per share) | $ 0.16 | $ 0.14 | $ 0.30 | $ 0.25 |
Diluted (in dollars per share) | $ 0.15 | $ 0.12 | $ 0.28 | $ 0.23 |
Stock options | ||||
Denominator | ||||
Dilutive effect of share-based payment (in shares) | 15,673 | 20,595 | 16,573 | 21,178 |
Other share-based awards | ||||
Denominator | ||||
Dilutive effect of share-based payment (in shares) | 107 | 94 | 173 | 77 |
Net Income Per Share Attribut_4
Net Income Per Share Attributable to Common Stockholders - Antidilutive Securities Excluded from Computation of Net Income Per Share (Details) - shares shares in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 2,181 | 1,027 | 1,427 | 1,028 |
Other share-based awards | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 1,665 | 511 | 911 | 512 |
Common stock warrants | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of net income per share (in shares) | 516 | 516 | 516 | 516 |
Restructuring - Narrative (Deta
Restructuring - Narrative (Details) - USD ($) $ in Thousands | 2 Months Ended | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restructuring Cost and Reserve [Line Items] | |||||
Number of positions eliminated as a percentage of total positions | 10% | ||||
Restructuring charges | $ 7,936 | $ 0 | $ 7,936 | $ 0 | |
Employee Severance | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | 4,289 | ||||
Stock-Based Compensation Expense, Accelerated Vesting Of Equity Awards | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring charges | $ 3,600 |
Restructuring - Activities Rela
Restructuring - Activities Related to the Restructuring (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restructuring Reserve [Roll Forward] | ||||
Liability as of July 1, 2023 | $ 0 | |||
Restructuring charges | 7,936 | $ 0 | $ 7,936 | $ 0 |
Payments | (3,748) | |||
Liability as of September 30, 2023 | 541 | $ 541 | ||
Employee Severance | ||||
Restructuring Reserve [Roll Forward] | ||||
Restructuring charges | $ 4,289 |
Commitments and Contingencies (
Commitments and Contingencies (Details) - USD ($) $ in Millions | 6 Months Ended | |
Oct. 08, 2021 | Sep. 30, 2023 | |
Other Commitments [Line Items] | ||
Partnership agreement, extension period | 6 years | |
Partnerships agreement, period before termination is permitted | 3 years | |
Partnership agreement, noncancelable period | 1 year | |
Partnership agreement, revenue guarantee during noncancelable period | $ 3.6 | |
Partnership agreement, revenue guarantee, expected payment period | 1 year | |
Hosting arrangement period | 3 years | |
Hosting arrangement annual commitment | $ 5.2 | |
Hosting arrangement remaining commitment | $ 5.2 | |
Hosting arrangement remaining commitment, expected payment period | 1 year | |
Minimum | ||
Other Commitments [Line Items] | ||
Partnership agreement, annual revenue guarantee to partnering company | $ 3.6 | |
Maximum | ||
Other Commitments [Line Items] | ||
Partnership agreement, annual revenue guarantee to partnering company | $ 6.2 |
Leases - Components of Lease Ex
Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Leases [Abstract] | ||||
Operating lease cost | $ 701 | $ 701 | $ 1,402 | $ 1,190 |
Variable lease cost | 45 | 133 | 65 | 173 |
Total lease cost | $ 746 | $ 834 | $ 1,467 | $ 1,363 |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Leases [Abstract] | ||
Cash paid for amounts included in measurement of lease liabilities—Operating cash flows | $ 907 | $ 389 |
Leases - Supplemental Balance S
Leases - Supplemental Balance Sheet Information (Details) | Sep. 30, 2023 | Mar. 31, 2023 |
Leases [Abstract] | ||
Weighted-average remaining lease term (in years) | 6 years 8 months 4 days | 7 years 21 days |
Weighted-average discount rate | 4.19% | 4.18% |
Leases - Maturities of Lease Li
Leases - Maturities of Lease Liabilities (Details) $ in Thousands | Sep. 30, 2023 USD ($) |
Leases [Abstract] | |
Remainder of 2024 | $ 1,331 |
2025 | 2,411 |
2026 | 2,458 |
2027 | 2,497 |
2028 | 2,605 |
Thereafter | 6,052 |
Total future lease payments | 17,354 |
Less: imputed interest | (2,300) |
Present value of lease liabilities | $ 15,054 |
Other Income, net (Details)
Other Income, net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Other Income and Expenses [Abstract] | ||||
Interest income | $ 5,822 | $ 1,419 | $ 10,840 | $ 2,269 |
Realized gain (loss) on sale and redemption of marketable securities | 131 | (463) | (142) | (463) |
Other income (expense) | (50) | (48) | 44 | (94) |
Other income, net | $ 5,903 | $ 908 | $ 10,742 | $ 1,712 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |||||
Effective tax rate | 22.90% | 20.30% | 20.50% | 12.30% | |
Unrecognized tax benefits | $ 8.7 | $ 8.7 | $ 7.9 | ||
Unrecognized tax benefits that would impact effective tax rate | $ 6.5 | $ 6.5 |
Segment and Geographic Inform_2
Segment and Geographic Information (Details) | 6 Months Ended |
Sep. 30, 2023 segment | |
Segment Reporting [Abstract] | |
Number of operating segments | 1 |
Number of reportable segments | 1 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Millions | Oct. 26, 2023 | Jun. 01, 2023 | Oct. 28, 2022 | May 12, 2022 |
Subsequent Event [Line Items] | ||||
Stock repurchase program, authorized amount | $ 200 | $ 70 | $ 70 | |
Stock repurchase program, period in force | 24 months | 12 months | ||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Stock repurchase program, authorized amount | $ 70 | |||
Stock repurchase program, period in force | 12 months |